negative effects of glp 1 drugs liraglutide (GLP-1 receptor agonist) – Efficacy and Adverse Mapping the effectiveness and risks
Description
Clinical trials comparing the two drugs directly are already underway at Eli Lilly, and that data will eventually inform switching protocols
Feighery AM, Oblizajek NR, Vogt MNP, et al
Int J Mol Sci 2020, 21(4)
:max_bytes(150000):strip_icc()/Common-Symptoms-From-Taking-a-GLP-1-And-How-to-Manage-Them-9e5bb7cee0484522a50dd9d7ce954cc4.jpg)
Of these articles, one was an open-label study ( 3.3 Summary of Outcomes 3.3.1 Efficacy Outcomes 3.3.1.1 HbA1c Overall, all 8 articles (Zinman et al., 2019
Tissue slides were then left at RT for 10 min and the remaining OCT was washed with PBS
These findings align with prior randomized trials and meta-analyses suggesting class-level cardiovascular benefit
